Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PWOD
5801
DELISTED
Penns Woods Bancorp
PWOD
| $39K | ﹤0.01% |
1,247
+935
| +300% | +$29.9K |
|
5802
Uranium Energy
UEC
$4.75B
| $39K | ﹤0.01% |
22,332
+18,486
| +481% | +$26K |
|
5803
INNOVATE Corp
VATE
$111M
| $39K | ﹤0.01% |
+660
| New | +$35.6K |
|
|
ITI
5804
DELISTED
Iteris, Inc.
ITI
| $39K | ﹤0.01% |
5,695
+4,624
| +432% | +$31.4K |
|
|
SFE
5805
DELISTED
Safeguard Scientifics, Inc.
SFE
| $39K | ﹤0.01% |
3,483
+2,858
| +457% | +$36.6K |
|
|
GHL
5806
CALL
DELISTED
Greenhill & Co., Inc.
GHL
| $39K | ﹤0.01% |
2,000
-48,000
| -96% | -$893K |
|
|
BSTC
5807
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $39K | ﹤0.01% |
896
+765
| +584% | +$34.4K |
|
|
CHU
5808
PUT
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $39K | ﹤0.01% |
2,900
+1,800
| +164% | +$25.8K |
|
5809
CALL
Aegon
AEG
$14B
| $38K | ﹤0.01% |
7,501
+5,779
| +336% | +$28.2K |
|
|
AMRN
5810
PUT
Amarin Corp
AMRN
$299M
| $38K | ﹤0.01% |
475
-115
| -19% | -$7.93K |
|
5811
AMES National
ATLO
$271M
| $38K | ﹤0.01% |
1,358
+1,159
| +582% | +$34.2K |
|
|
BELFB
5812
Bel Fuse Inc Class B
BELFB
$3.87B
| $38K | ﹤0.01% |
1,535
-998
| -39% | -$28.6K |
|
|
BFIN
5813
DELISTED
BankFinancial
BFIN
| $38K | ﹤0.01% |
2,489
+1,921
| +338% | +$30.7K |
|
5814
Cibus
CBUS
$147M
| $38K | ﹤0.01% |
34
-12
| -26% | -$13.6K |
|
5815
Fate Therapeutics
FATE
$286M
| $38K | ﹤0.01% |
6,228
+3,545
| +132% | +$15.8K |
|
5816
PUT
Flotek Industries
FTK
$852M
| $38K | ﹤0.01% |
1,367
+284
| +26% | +$8.09K |
|
5817
Ooma
OOMA
$598M
| $38K | ﹤0.01% |
3,159
+2,757
| +686% | +$29.3K |
|
5818
Rhythm Pharmaceuticals
RYTM
$6.81B
| $38K | ﹤0.01% |
+1,306
| New | +$34.5K |
|
|
SNBR
5819
PUT
DELISTED
Sleep Number
SNBR
| $38K | ﹤0.01% |
1,000
| – | – |
|
|
SNV
5820
PUT
DELISTED
Synovus
SNV
| $38K | ﹤0.01% |
800
+600
| +300% | +$28.4K |
|
5821
Sportsman's Warehouse
SPWH
$44.5M
| $38K | ﹤0.01% |
5,741
+4,901
| +583% | +$23.5K |
|
5822
PUT
ProShares Ultra Financials
UYG
$828M
| $38K | ﹤0.01% |
900
+600
| +200% | +$24.2K |
|
|
SBOW
5823
DELISTED
SilverBow Resources, Inc.
SBOW
| $38K | ﹤0.01% |
1,277
+905
| +243% | +$21.1K |
|
|
CSLT
5824
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $38K | ﹤0.01% |
10,157
+8,674
| +585% | +$34.7K |
|
|
KIN
5825
DELISTED
Kindred Biosciences, Inc.
KIN
| $38K | ﹤0.01% |
3,990
+3,406
| +583% | +$26.6K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.